Exact Mass: 397.1324

Exact Mass Matches: 397.1324

Found 55 metabolites which its exact mass value is equals to given mass value 397.1324, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

acutumine

(1S,4S,6S,10R,11S)-11-chloro-4-hydroxy-3,4,5-trimethoxy-7-methylspiro[7-azatricyclo[4.3.3.01,6]dodec-4-ene-10,5-cyclopent-2-ene]-1,3-dione

C19H24ClNO6 (397.1292)


Acutumine is an alkaloid. Acutumine is a natural product found in Hypserpa nitida, Sinomenium acutum, and other organisms with data available. Dauricumine is a natural product found in Hypserpa nitida, Sinomenium acutum, and Menispermum dauricum with data available.

   

1-(4-Acetyl-2-pyrrolidin-1-ylmethyl-piperazin-1-yl)-2-(3,4-dichloro-phenyl)-ethanone

Methyl 4-((3,4-dichlorophenyl)acetyl)-3-(1-pyrrolidinylmethyl)-1-piperazinecarboxylate fumarate

C19H25Cl2N3O2 (397.1324)


   

2-Methylthioribosylzeatin

2-Methylthioribosyl-trans-zeatin

C16H23N5O5S (397.142)


   
   

(S)-tryptophan-betaxanthin

(S)-tryptophan-betaxanthin

C20H19N3O6 (397.1274)


   

6-hydroxymetatacarboline A

6-hydroxymetatacarboline A

C20H19N3O6 (397.1274)


   

(2S)-2-{[(1-acetyl-9H-beta-carbolin-3-yl)carbonyl]amino}-5-methoxy-5-oxopentanoic acid|dichotomine G|N-[(1-acetyl-9H-pyrido[3,4-b]indol-3-yl)carbonyl]-L-glutamic acid 5-methyl ester|tunicoidine E

(2S)-2-{[(1-acetyl-9H-beta-carbolin-3-yl)carbonyl]amino}-5-methoxy-5-oxopentanoic acid|dichotomine G|N-[(1-acetyl-9H-pyrido[3,4-b]indol-3-yl)carbonyl]-L-glutamic acid 5-methyl ester|tunicoidine E

C20H19N3O6 (397.1274)


   
   
   

2-Methylthio-trans-zeatin Riboside (2MeStZR)

2-Methylthio-trans-zeatin Riboside (2MeStZR)

C16H23N5O5S (397.142)


   
   
   
   
   
   
   

Trp-Ala-OH

(S)-2-(3-(2-(1H-indol-2-yl)ethoxy)-4-nitrobenzamido)propanoic acid

C20H19N3O6 (397.1274)


   

Abu-Trp-OH

(S)-2-(3-ethoxy-4-nitrobenzamido)-3-(1H-indol-3-yl)propanoic acid

C20H19N3O6 (397.1274)


   

1,4-bis(phenylmethoxycarbonyl)piperazine-2-carboxylate

1,4-bis(phenylmethoxycarbonyl)piperazine-2-carboxylate

C21H21N2O6 (397.14)


   

2-[4-[2-hydroxy-2-(3-phenoxypropylamino)ethoxy]phenoxy]acetic acid,hydrochloride

2-[4-[2-hydroxy-2-(3-phenoxypropylamino)ethoxy]phenoxy]acetic acid,hydrochloride

C19H24ClNO6 (397.1292)


   

(S)-Duloxetine Succinamide

(S)-Duloxetine Succinamide

C22H23NO4S (397.1348)


   

H-Ala-Pro-AFC

H-Ala-Pro-AFC

C18H18F3N3O4 (397.1249)


H-Ala-Pro-AFC is a biological active peptide. (This is a fluorescent peptide, Abs/Em=380/500nm. It is a substrate for dipeptidyl peptidase IV (DPP IV) and Xaa-Pro dipeptidase.)

   

Glycopyrrolate

Glycopyrrolate

C19H28BrNO3 (397.1252)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BB - Anticholinergics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D002491 - Central Nervous System Agents Glycopyrrolate (Glycopyrronium bromide), a quaternary ammonium derivative, is a muscarinic receptor antagonist. Glycopyrrolate has bronchoprotective effect and produces a beneficial effect on blood pressure. Glycopyrrolate can be used for the research of bronchial diseases[1][2][3].

   
   

SD-06

2-{4-[5-(4-Chlorophenyl)-4-Pyrimidin-4-Yl-1h-Pyrazol-3-Yl]piperidin-1-Yl}-2-Oxoethanol

C20H20ClN5O2 (397.1305)


   

Beryllium bisbenzo[h]quinolin-10-olate

Beryllium bisbenzo[h]quinolin-10-olate

C26H16BeN2O2 (397.1334)


   

(R,R)-Glycopyrrolate

(R,R)-Glycopyrrolate

C19H28BrNO3 (397.1252)


   

threo-Glycopyrronium bromide

threo-Glycopyrronium bromide

C19H28BrNO3 (397.1252)


   

Glycopyrronium bromide

erythro-Glycopyrronium bromide

C19H28BrNO3 (397.1252)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BB - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D002491 - Central Nervous System Agents

   

2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-(thian-4-yl)acetic acid

2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-(thian-4-yl)acetic acid

C22H23NO4S (397.1348)


   

2-methylthio-N(6)-(cis-4-hydroxy-Delta(2)-isopentenyl)adenosine

2-methylthio-N(6)-(cis-4-hydroxy-Delta(2)-isopentenyl)adenosine

C16H23N5O5S (397.142)


   

Pyrrolidinium, 3-(((2S)-cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, bromide, (3R)-

Pyrrolidinium, 3-(((2S)-cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, bromide, (3R)-

C19H28BrNO3 (397.1252)


   

S-Benzylglutathione

S-Benzylglutathione

C17H23N3O6S (397.1307)


   

N-[3-(4-phenyl-2-thiazolyl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]acetamide

N-[3-(4-phenyl-2-thiazolyl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]acetamide

C21H23N3OS2 (397.1282)


   

3-[3-[4-(3-Chlorophenyl)-1-piperazinyl]-3-oxopropyl]-4-pyrido[2,3-d]pyrimidinone

3-[3-[4-(3-Chlorophenyl)-1-piperazinyl]-3-oxopropyl]-4-pyrido[2,3-d]pyrimidinone

C20H20ClN5O2 (397.1305)


   

3-[(2E)-2-(2,4-dihydroxybenzylidene)hydrazinyl]-6-(3,4-dimethoxybenzyl)-1,2,4-triazin-5(2H)-one

3-[(2E)-2-(2,4-dihydroxybenzylidene)hydrazinyl]-6-(3,4-dimethoxybenzyl)-1,2,4-triazin-5(2H)-one

C19H19N5O5 (397.1386)


   
   
   
   
   
   
   

(1s,1's,5s,6's,8's)-8'-chloro-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

(1s,1's,5s,6's,8's)-8'-chloro-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

C19H24ClNO6 (397.1292)


   

(2s,4e)-4-[(2z)-2-{[(1s)-1-carboxy-2-(1h-indol-3-yl)ethyl]imino}ethylidene]-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

(2s,4e)-4-[(2z)-2-{[(1s)-1-carboxy-2-(1h-indol-3-yl)ethyl]imino}ethylidene]-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

C20H19N3O6 (397.1274)


   

acutumine

SMR001397290; MLS002473201; NCGC00247495-01; CHEMBL1716763; HMS2196C12; Acutumine

C19H24ClNO6 (397.1292)


{"Ingredient_id": "HBIN014665","Ingredient_name": "acutumine","Alias": "SMR001397290; MLS002473201; NCGC00247495-01; CHEMBL1716763; HMS2196C12; Acutumine","Ingredient_formula": "C19H24ClNO6","Ingredient_Smile": "CN1CCC23C1(CC(C24C(C(=CC4=O)OC)O)Cl)C(=C(C(=O)C3)OC)OC","Ingredient_weight": "397.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT01252;SMIT03174","TCMID_id": "603","TCMSP_id": "MOL000619;MOL012908","TCM_ID_id": "7164","PubChem_id": "101286230","DrugBank_id": "NA"}

   

(5s,8's)-8'-chloro-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

(5s,8's)-8'-chloro-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

C19H24ClNO6 (397.1292)


   

8'-chloro-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

8'-chloro-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

C19H24ClNO6 (397.1292)


   

1-(3-{3-carboxy-6-hydroxy-9h-pyrido[3,4-b]indol-1-yl}propanoyl)pyrrolidine-2-carboxylic acid

1-(3-{3-carboxy-6-hydroxy-9h-pyrido[3,4-b]indol-1-yl}propanoyl)pyrrolidine-2-carboxylic acid

C20H19N3O6 (397.1274)


   

(2s)-1-(3-{3-carboxy-6-hydroxy-9h-pyrido[3,4-b]indol-1-yl}propanoyl)pyrrolidine-2-carboxylic acid

(2s)-1-(3-{3-carboxy-6-hydroxy-9h-pyrido[3,4-b]indol-1-yl}propanoyl)pyrrolidine-2-carboxylic acid

C20H19N3O6 (397.1274)


   

6-[2-(1,4-dihydroxy-4-methylpentyl)-1,3-thiazol-4-yl]-3-hydroxy-4,5-dimethoxypyridine-2-carboximidic acid

6-[2-(1,4-dihydroxy-4-methylpentyl)-1,3-thiazol-4-yl]-3-hydroxy-4,5-dimethoxypyridine-2-carboximidic acid

C17H23N3O6S (397.1307)


   

(4e)-4-(2-{[1-carboxy-2-(1h-indol-3-yl)ethyl]imino}ethylidene)-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

(4e)-4-(2-{[1-carboxy-2-(1h-indol-3-yl)ethyl]imino}ethylidene)-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

C20H19N3O6 (397.1274)


   

(1s,1's,5r,6's,8's)-8'-chloro-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

(1s,1's,5r,6's,8's)-8'-chloro-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

C19H24ClNO6 (397.1292)


   

(2s,4z)-4-(2-{[(1s)-1-carboxy-2-(1h-indol-3-yl)ethyl]imino}ethylidene)-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

(2s,4z)-4-(2-{[(1s)-1-carboxy-2-(1h-indol-3-yl)ethyl]imino}ethylidene)-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid

C20H19N3O6 (397.1274)


   

(1r,1's,5r,6's,8's)-8'-chloro-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

(1r,1's,5r,6's,8's)-8'-chloro-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

C19H24ClNO6 (397.1292)


   

(2r,3s,4r,5r)-2-(6-{[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]amino}-2-(methylsulfanyl)purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

(2r,3s,4r,5r)-2-(6-{[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]amino}-2-(methylsulfanyl)purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C16H23N5O5S (397.142)